Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary liver cancer (hepatocellular carcinoma) or a different type of liver cancer that is not hepatocellular carcinoma.
- People who are able to read, understand, and sign a consent form, or who have a legal representative who can do this on their behalf.
- People who agree to provide blood samples and are willing to follow the study requirements consistently.
- People who have complete basic medical information on file, including a unique identification number (such as an ID card number, outpatient number, or health insurance card number), age, gender, and relevant imaging and/or pathology results.
Who may not be able to join:
- People who are pregnant.
- People who have previously received an organ transplant.
- People who have a type of liver cancer other than hepatocellular carcinoma and who have also been diagnosed with a separate, different type of cancer.
- People who have primary hepatocellular carcinoma along with another type of cancer at the same time.
- People whom the research team determines do not meet the required criteria for the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: zhang yewei, doctor, Nanjing Medical University
Phone: +86 13813885788
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and Specificity of the Novel Protein Indicator; Positive and Negative Predictive Values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.